Cargando…

Phase I Trial of a Lactobacillus crispatus Vaginal Suppository for Prevention of Recurrent Urinary Tract Infection in Women

Objectives: We performed a phase I trial to assess the safety and tolerance of a Lactobacillus vaginal suppository for prevention of recurrent UTI. Methods: Premenopausal women with a history of recurrent UTI were randomized to use L. crispatus CTV-05 or placebo vaginal suppositories daily for five...

Descripción completa

Detalles Bibliográficos
Autores principales:	Czaja, Christopher A., Stapleton, Ann E., Yarova-Yarovaya, Yuliya, Stamm, Walter E.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2007
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2216064/ https://www.ncbi.nlm.nih.gov/pubmed/18288237 http://dx.doi.org/10.1155/2007/35387

Ejemplares similares

Can vaginal lactobacillus suppositories help reduce urinary tract infections?
por: Shoureshi, Poone S., et al.
Publicado: (2023)

Etiology of recurrent cystitis in postmenopausal women based on vaginal microbiota and the role of Lactobacillus vaginal suppository
por: Sekito, Takanori, et al.
Publicado: (2023)

Characterization of the first vaginal Lactobacillus crispatus genomes isolated in Brazil
por: Oliveira de Almeida, Marcelle, et al.
Publicado: (2021)

Cytoprotective Effect of Lactobacillus crispatus CTV-05 against Uropathogenic E. coli
por: Butler, Daniel S. C., et al.
Publicado: (2016)

126. Robust and Persistent Vaginal Colonization with LACTIN-V Vaginal Lactobacillus crispatus Probiotic in a Double-Blind, Placebo-Controlled (DBPC) Phase 2b Trial to Prevent Recurrent UTI (rUTI)
por: Stapleton, Ann, et al.
Publicado: (2018)

Draft Genome Sequence of a Urinary Isolate of Lactobacillus crispatus
por: Price, Travis K., et al.
Publicado: (2016)

The core genome evolution of Lactobacillus crispatus as a driving force for niche competition in the human vaginal tract
por: Tarracchini, Chiara, et al.
Publicado: (2023)

Vaginal microbiome Lactobacillus crispatus is heritable among European American women
por: Wright, Michelle L., et al.
Publicado: (2021)

Evaluation of Modulatory Activities of Lactobacillus crispatus Strains in the Context of the Vaginal Microbiota
por: Argentini, Chiara, et al.
Publicado: (2022)

Variability of the response of human vaginal Lactobacillus crispatus to 17β-estradiol
por: Clabaut, Maximilien, et al.
Publicado: (2021)

Draft Genome Sequence of Lactobacillus crispatus UMB1163, Isolated from the Female Urinary Tract
por: Khan, Fabeiha, et al.
Publicado: (2020)

Lactobacillus crispatus Modulates Vaginal Epithelial Cell Innate Response to Candida albicans
por: Niu, Xiao-Xi, et al.
Publicado: (2017)

Effect of 17β-estradiol on a human vaginal Lactobacillus crispatus strain
por: Clabaut, Maximilien, et al.
Publicado: (2021)

Enhanced IgA coating of bacteria in women with Lactobacillus crispatus-dominated vaginal microbiota
por: Breedveld, Annelot C., et al.
Publicado: (2022)

Lactobacillus crispatus Dominant Vaginal Microbiome Is Associated with Inhibitory Activity of Female Genital Tract Secretions against Escherichia coli
por: Ghartey, Jeny P., et al.
Publicado: (2014)

Exploring the antimicrobial properties of vaginal Lactobacillus crispatus against preterm birth-associated bacteria
por: Amabebe, Emmanuel, et al.
Publicado: (2022)

Improvement of vaginal probiotics Lactobacillus crispatus on intrauterine adhesion in mice model and in clinical practice
por: Wu, Fei, et al.
Publicado: (2023)

Comparative Analysis of Lactobacillus gasseri and Lactobacillus crispatus Isolated From Human Urogenital and Gastrointestinal Tracts
por: Pan, Meichen, et al.
Publicado: (2020)

Evaluation of the Inhibitory Effects of Lactobacillus gasseri and Lactobacillus crispatus on the Adhesion of Seven Common Lower Genital Tract Infection-Causing Pathogens to Vaginal Epithelial Cells
por: He, Yuanhui, et al.
Publicado: (2020)

Diverse Expression of Antimicrobial Activities Against Bacterial Vaginosis and Urinary Tract Infection Pathogens by Cervicovaginal Microbiota Strains of Lactobacillus gasseri and Lactobacillus crispatus
por: Atassi, Fabrice, et al.
Publicado: (2019)

Draft Genome Sequence of Lactobacillus crispatus CIP 104459, Isolated from a Vaginal Swab
por: Clabaut, Maximilien, et al.
Publicado: (2020)

Vaginal Probiotic Lactobacillus crispatus Seems to Inhibit Sperm Activity and Subsequently Reduces Pregnancies in Rat
por: Li, Ping, et al.
Publicado: (2021)

Draft Genome Sequence of Lactobacillus crispatus 2029
por: Karlyshev, Andrey V., et al.
Publicado: (2014)

Lactobacillus crispatus inhibits growth of Gardnerella vaginalis and Neisseria gonorrhoeae on a porcine vaginal mucosa model
por: Breshears, Laura M., et al.
Publicado: (2015)

Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion
por: De Gregorio, Priscilla Romina, et al.
Publicado: (2020)

Protective Effect of Lactobacillus crispatus against Vaginal Colonization with Group B Streptococci in the Third Trimester of Pregnancy
por: Starc, Maja, et al.
Publicado: (2022)

Lactobacillus crispatus‐dominated vaginal microbiome and Acinetobacter‐dominated seminal microbiome support beneficial ART outcome
por: Koort, Kairi, et al.
Publicado: (2023)

Interstrain Variability of Human Vaginal Lactobacillus crispatus for Metabolism of Biogenic Amines and Antimicrobial Activity against Urogenital Pathogens
por: Puebla-Barragan, Scarlett, et al.
Publicado: (2021)

Release of Tenofovir from Carrageenan-Based Vaginal Suppositories
por: Zaveri, Toral, et al.
Publicado: (2014)

Firmness Perception Influences Women’s Preferences for Vaginal Suppositories
por: Zaveri, Toral, et al.
Publicado: (2014)

Consistent Condom Use Increases the Colonization of Lactobacillus crispatus in the Vagina
por: Ma, Liyan, et al.
Publicado: (2013)

Host and body site-specific adaptation of Lactobacillus crispatus genomes
por: Pan, Meichen, et al.
Publicado: (2020)

Genetic Elements Orchestrating Lactobacillus crispatus Glycogen Metabolism in the Vagina
por: Hertzberger, Rosanne, et al.
Publicado: (2022)

Orally administrated Lactobacillus gasseri TM13 and Lactobacillus crispatus LG55 can restore the vaginal health of patients recovering from bacterial vaginosis
por: Qi, Fengyuan, et al.
Publicado: (2023)

Boric acid vaginal suppositories: a brief review.
por: Prutting, S M, et al.
Publicado: (1998)

Comparative genomics of human Lactobacillus crispatus isolates reveals genes for glycosylation and glycogen degradation: implications for in vivo dominance of the vaginal microbiota
por: van der Veer, Charlotte, et al.
Publicado: (2019)

Complete Genome Sequence of Lactobacillus crispatus CO3MRSI1
por: McComb, Elias, et al.
Publicado: (2019)

Complete Genome Sequence of Lactobacillus crispatus Type Strain ATCC 33820
por: Teodori, Lucia, et al.
Publicado: (2021)

Behavioral Predictors of Colonization with Lactobacillus crispatus or Lactobacillus jensenii after Treatment for Bacterial Vaginosis: A Cohort Study
por: Mitchell, Caroline, et al.
Publicado: (2012)

Vaginal mucosal vaccine for recurrent urinary tract infections
por: Gautam, Gagan, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_0dbnqfm3i7a4klvur67fq68pks